# Chapter 13: Provisional Tic Disorder

# Chapter X: The Biological and Neurological Basis of Provisional Tic Disorder

## Introduction

Provisional Tic Disorder (PTD) represents the most common form of tic disorder, characterized by the presence of one or more motor or vocal tics for a duration of less than one year, with an onset before the age of 18 (Scahill et al., 2009; Abi‐Jaoude & Gorman, 2012). While often transient, PTD provides a critical window into the incipient stages of the neurobiological processes that, in a subset of individuals, may progress to more persistent conditions such as Chronic Tic Disorder or Tourette Syndrome (TS) (Senberg & Roessner, 2021). Understanding the biological underpinnings of PTD is therefore paramount, not only for elucidating its own pathophysiology but also for understanding the broader spectrum of tic disorders.

From a biological perspective, PTD is conceptualized as a neurodevelopmental disorder, emerging during critical periods of brain maturation (Blows, 2003; Rothenberger & Banaschewski, 2006). The transient nature of the majority of these cases suggests a dynamic interplay between underlying vulnerabilities and the brain's remarkable capacity for neuroplasticity and compensation (Senberg & Roessner, 2021). The etiology is considered multifactorial, involving a complex interaction of genetic predispositions, neurobiological factors, and environmental influences (Senberg & Roessner, 2021; García-Acero & Espinosa, 2018).

This chapter aims to provide a comprehensive overview of the biological and neurological basis of PTD. It is crucial to acknowledge a significant limitation at the outset: the available research literature, as represented by the sources for this chapter, focuses almost exclusively on the more severe and persistent forms of tic disorders, namely Tourette Syndrome and Chronic Tic Disorder. Direct biological investigations into PTD are conspicuously absent. Consequently, the following synthesis is necessarily an extrapolation, drawing upon the robust findings from TS research under the prevailing hypothesis that all tic disorders exist on a continuum and share fundamental pathophysiological mechanisms (Senberg & Roessner, 2021; Vocke & Neuner, 2012). We will explore the implicated neurotransmitter systems, neural circuits, and genetic foundations that are believed to give rise to the involuntary, repetitive movements and vocalizations characteristic of tics. By examining the neurobiology of the broader tic disorder spectrum, we can construct a scientifically informed model of the likely mechanisms at play in PTD, while simultaneously highlighting the urgent need for research focused specifically on this common, yet understudied, condition.

## Neurobiological Systems

The prevailing neurobiological model for tic disorders, including by extension PTD, implicates dysfunction within specific cortico-subcortical neural circuits (Vocke & Neuner, 2012; García-Acero & Espinosa, 2018). These circuits are crucial for motor control, habit formation, and the regulation of voluntary action. The expression of tics is thought to arise from a failure of inhibitory mechanisms within these pathways, leading to the unwanted release of motor programs. Central to this model are the cortico-striato-thalamo-cortical (CSTC) loops, with a particular emphasis on neurotransmitter systems that modulate their activity, most notably dopamine (Jakubovski & Müller‐Vahl, 2017; Vocke & Neuner, 2012).

### Cortico-Striato-Thalamo-Cortical (CSTC) Circuits

The CSTC loops are a set of parallel, largely segregated neural circuits that connect regions of the cerebral cortex with the basal ganglia (striatum, globus pallidus, subthalamic nucleus, substantia nigra) and the thalamus, before projecting back to the cortex (Vocke & Neuner, 2012). These loops are involved in a wide range of functions, including motor, cognitive, and emotional processing. The motor circuit, which originates in the supplementary motor area, premotor cortex, and primary motor cortex, is considered the primary substrate for tic generation (García-Acero & Espinosa, 2018).

In the context of tic disorders, the pathophysiology is hypothesized to involve a disruption in the delicate balance between the "direct" and "indirect" pathways within the basal ganglia component of these loops (Vocke & Neuner, 2012). The direct pathway generally facilitates movement, while the indirect pathway inhibits it. A leading theory posits that tics result from excessive, phasic activity in the direct pathway and/or insufficient tonic inhibition from the indirect pathway. This imbalance is thought to lower the threshold for triggering motor actions, leading to the involuntary release of tic behaviors that are experienced as compulsive phenomena (Pestana, 2015). The sensory premonitory urge that often precedes a tic is thought to originate from cortical or limbic inputs into these circuits, representing a build-up of sensorimotor tension that is relieved by the execution of the tic (Vocke & Neuner, 2012). The transient suppressibility of tics, a key clinical feature, likely reflects the temporary and effortful recruitment of prefrontal cortical control over these dysregulated subcortical structures (Vocke & Neuner, 2012).

### Neurotransmitter Systems and Neuropharmacology

The strongest evidence for neurochemical abnormalities in tic disorders comes from neuropharmacological studies and the clinical efficacy of certain medications (Jakubovski & Müller‐Vahl, 2017; Senberg & Roessner, 2021). The dopamine system, in particular, has been a central focus of research.

**The Dopamine Hypothesis:** The dopamine hypothesis of tic disorders suggests that tics arise from a state of dopaminergic hyperinnervation or supersensitivity within the striatum, a key input nucleus of the basal ganglia (Vocke & Neuner, 2012). This leads to excessive activation of the direct pathway and a corresponding disinhibition of thalamo-cortical projections, ultimately facilitating the expression of unwanted motor programs as tics. Several lines of evidence support this hypothesis. First, dopamine receptor antagonists (antipsychotics) are the most effective pharmacological agents for tic suppression (Senberg & Roessner, 2021; Vocke & Neuner, 2012). Medications such as haloperidol, risperidone, and aripiprazole, which block dopamine D2 receptors, can significantly reduce tic severity, although they do not cure the disorder (Jakubovski & Müller‐Vahl, 2017; Vocke & Neuner, 2012). The recommendation to use substances like tiapride and sulpirid further underscores the focus on dopamine antagonism in treatment strategies (Vocke & Neuner, 2012).

Conversely, dopamine-enhancing agents, such as stimulants used to treat comorbid Attention-Deficit/Hyperactivity Disorder (ADHD), have been anecdotally reported to exacerbate tics in some individuals, although this relationship is complex and not universally observed (Senberg & Roessner, 2021). The fluctuating nature of tics, which can wax and wane over minutes, days, and years, may reflect dynamic changes in dopamine release and receptor sensitivity within the CSTC circuits (Senberg & Roessner, 2021). For example, tics are often exacerbated by situations of anxiety and emotional tension, which are known to modulate dopamine activity (Pestana, 2015).

**Other Neurotransmitter Systems:** While dopamine has received the most attention, it is unlikely to be the sole neurotransmitter involved. The CSTC circuits are modulated by a complex interplay of various neurochemicals. Glutamate, the brain's primary excitatory neurotransmitter, and gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter, are critical for the normal functioning of these loops. A disruption in the balance between glutamatergic cortical inputs and GABAergic striatal outputs could contribute to the disinhibition underlying tics.

The serotonergic system, which is heavily implicated in comorbid obsessive-compulsive disorder (OCD) and anxiety disorders (Lepola et al., 2024; Bober & Martin, 2006), also projects widely to the basal ganglia and may play a modulatory role. The high rate of comorbidity between tics and OCD suggests a potential shared neurobiological substrate involving these systems (Senberg & Roessner, 2021). Similarly, noradrenergic systems, involved in arousal and stress responses, may influence tic expression, given the known sensitivity of tics to emotional states (Pestana, 2015). The multifactorial etiology of tic disorders strongly suggests that the underlying neurobiology involves a complex dysregulation across multiple interacting neurotransmitter systems rather than a simple deficit or excess of a single chemical (Senberg & Roessner, 2021).

## Genetic and Molecular Basis

The etiology of tic disorders, from the transient presentation of PTD to the chronic course of Tourette Syndrome, is understood to be multifactorial, with a significant contribution from genetic factors (Senberg & Roessner, 2021; García-Acero & Espinosa, 2018). While environmental and psychosocial elements play a role in modulating symptom expression, the strong familial aggregation of tics points toward a substantial hereditary basis (Pestana, 2015; Abi‐Jaoude & Gorman, 2012). Most cases are believed to result from a complex interplay of multiple genes of small effect, interacting with each other and with environmental factors (Senberg & Roessner, 2021; Watson, 2013).

### Heritability and Familial Aggregation

Clinical observations have long noted that tic disorders run in families (Pestana, 2015; Abi‐Jaoude & Gorman, 2012). Studies of families with a member diagnosed with Tourette Syndrome often reveal a higher-than-expected prevalence of other tic disorders (including chronic tics and PTD) and related conditions like OCD among first-degree relatives (Senberg & Roessner, 2021; Vocke & Neuner, 2012). This familial clustering strongly suggests a shared genetic vulnerability. Case reports describing familial Tourette Syndrome have suggested patterns of inheritance consistent with an autosomal dominant model, where a single copy of a disease-associated mutation is enough to increase risk (García-Acero & Espinosa, 2018; Unknown, 2019). However, the expression of the disorder is not always straightforward, pointing to concepts like incomplete penetrance, where not all individuals with the genetic variant will manifest the disorder, and variable expressivity, where the severity and type of symptoms can differ greatly among affected family members (Kerbeshian et al., 1997; Spielman & Ewens, 2006).

The construct of canalization, which describes the capacity of a developmental pathway to resist genetic or environmental perturbations and produce a consistent phenotype, has been proposed as a useful framework for understanding the variable expression of tic disorders (Kerbeshian et al., 1997; Kerbeshian, 1997). In this view, a strong genetic liability might be necessary to overcome the canalized, typical developmental trajectory and result in the tic phenotype. The phenomenon of "genetic anticipation," where the age of onset becomes earlier and/or the severity of symptoms increases in successive generations, has also been considered (Unknown, 2019). This pattern is well-documented in disorders caused by trinucleotide repeat expansions, such as Huntington's disease (Lehman & Nance, 2013; Nelson & Zoghbi, 2006; Epplen & Wieczorek, 2007). While the specific molecular mechanisms of anticipation in tic disorders remain unconfirmed, the observation of earlier and more severe presentations in younger generations of some families suggests that dynamic mutations could be involved (Huret, 1997; Chiurazzi & Oostra, 2006).

### Candidate Genes and Molecular Pathways

The search for specific genes responsible for tic disorders has been challenging due to the likely genetic heterogeneity, meaning that different genes can lead to a similar clinical presentation (Senberg & Roessner, 2021). Nevertheless, research has begun to identify loci of susceptibility and candidate genes that provide clues about the underlying molecular mechanisms.

Early genetic linkage and association studies, which aim to identify chromosomal regions or specific gene variants that are co-inherited with the disorder, have pointed to several areas of interest (Spielman & Ewens, 2006; Narain, 2014). More recent studies have implicated genes involved in synaptic function and connectivity (García-Acero & Espinosa, 2018). This aligns well with the neurobiological model of tic disorders, which posits dysfunction within the CSTC circuits (Vocke & Neuner, 2012). Genes that code for proteins involved in neurotransmitter release, receptor function, reuptake mechanisms, and the structural integrity of the synapse are all plausible candidates. For example, genes related to the dopamine, serotonin, and glutamate systems have been investigated due to the known role of these neurotransmitters in modulating basal ganglia function (Jakubovski & Müller‐Vahl, 2017).

Beyond synaptic function, genes involved in broader neurodevelopmental processes are also of interest (Blows, 2003). Given that tics emerge during specific developmental windows in childhood and adolescence, genes that guide neuronal migration, axonal guidance, and synaptic pruning are likely to be relevant (Rothenberger & Banaschewski, 2006). A disruption in these fundamental processes could lead to the miswiring or improper maturation of the CSTC circuits, creating a vulnerable substrate for the development of tics. It is also plausible that some genetic risk is conferred through "epistasis," a circumstance where the expression of one gene is affected by one or more independently inherited genes (Unknown, 2019; Epistasis, 2019). This interaction between genes could help explain the incomplete penetrance and variable expressivity seen in tic disorders (Kerbeshian et al., 1997).

Ultimately, the genetic architecture of PTD and other tic disorders is likely to be highly complex, involving a combination of rare variants with large effects in some families and a collection of common variants with small effects in the broader population (García-Acero & Espinosa, 2018; Watson, 2013). The interaction of this genetic liability with various environmental factors, from prenatal influences to psychosocial stress, likely determines the final expression of the phenotype, including whether an individual develops transient tics that remit or a more chronic and persistent disorder (Senberg & Roessner, 2021).

## Brain Structure and Function

The investigation of brain structure and function in individuals with tic disorders provides a crucial bridge between the hypothesized circuit-level dysfunction and observable neuroanatomical and physiological correlates. While the provided literature does not contain specific neuroimaging studies on Provisional Tic Disorder, findings from studies on Tourette Syndrome and chronic tic disorders offer a valuable, albeit inferred, framework for understanding the potential neural substrates. The central hypothesis is that structural or functional alterations within the key nodes of the Cortico-Striato-Thalamo-Cortical (CSTC) circuits underlie the pathophysiology of tics (Vocke & Neuner, 2012; García-Acero & Espinosa, 2018).

### Structural Neuroimaging Findings

Structural neuroimaging techniques, such as Magnetic Resonance Imaging (MRI), allow for the detailed examination of brain anatomy, including the volume, shape, and integrity of different brain regions. Based on the CSTC model, research in chronic tic disorders has primarily focused on the basal ganglia—particularly the striatum (caudate nucleus and putamen)—as well as cortical regions involved in motor control and inhibition (Vocke & Neuner, 2012).

Although the available sources do not present direct MRI data, the CSTC model would predict potential alterations in these key regions. For instance, some studies in the broader literature have reported volumetric differences in the basal ganglia, with findings often suggesting smaller caudate volumes in children with tic disorders that may normalize in adulthood. This developmental trajectory could be interpreted as evidence of an initial maturational delay or an atypical developmental course within these critical motor control structures (Rothenberger & Banaschewski, 2006). Such a delay might be particularly relevant to PTD, which predominantly affects children and often resolves spontaneously, possibly reflecting the eventual "catching up" of these neural systems (Senberg & Roessner, 2021).

Furthermore, cortical regions, especially the prefrontal cortex and supplementary motor area, which provide top-down control and inhibitory signals to the striatum, are also regions of interest (García-Acero & Espinosa, 2018). It is hypothesized that subtle structural differences or delayed maturation in these frontal areas could compromise their ability to effectively suppress unwanted motor programs generated within the basal ganglia, thus permitting the expression of tics. The integrity of the white matter tracts connecting these cortical and subcortical regions is another area of investigation. Techniques like diffusion tensor imaging could theoretically reveal alterations in the structural connectivity of the CSTC pathways, though such studies are not available for review here.

### Functional Neuroimaging and Neurophysiological Findings

Functional neuroimaging techniques assess brain activity, either at rest or during specific tasks. The core hypothesis is that tic disorders are associated with abnormal patterns of activity and connectivity within the CSTC loops (Vocke & Neuner, 2012). Studies on chronic tic disorders have often shown hyperactivity in motor-related areas, including the supplementary motor area, primary motor cortex, and putamen, preceding and during tic execution. This is consistent with the model of a disinhibited motor system.

Conversely, activity in prefrontal and parietal cortical regions, which are involved in cognitive control and attention, is often observed during periods of voluntary tic suppression. This suggests an effortful, top-down attempt to control the hyperactive subcortical drive (Vocke & Neuner, 2012). In the context of PTD, one might speculate that the ability to successfully recruit these prefrontal control networks is a key determinant of whether tics remain transient or become chronic. The spontaneous remission so common in PTD could reflect a strengthening of these inhibitory pathways through neuroplastic processes during development (Senberg & Roessner, 2021).

Neurophysiological methods also provide insights into brain function. Electroencephalography (EEG) studies in patients with chronic tic disorders have sometimes revealed non-specific abnormalities, but no consistent epileptic-like patterns are associated with the tics themselves (Baumgartner et al., 2013). This helps to differentiate tics from other paroxysmal movement disorders like myoclonic seizures (Dubru et al., 2002). Some research has pointed to alterations in preparatory motor potentials, suggesting that the brain's readiness to execute a movement is dysregulated.

One particularly intriguing finding, described by Enoch et al. (1991), involves unique, fluctuating step-like visual field defects in individuals with Tourette Syndrome and their relatives. While the direct link between this visual system anomaly and the motor symptoms of tics is not clear, the authors suggest it may reflect a broader anomaly of the dopaminergic system, which is known to modulate both motor and sensory functions (Enoch et al., 1991). This finding highlights that the neurobiological disruption in tic disorders may not be confined solely to the motor pathways but could represent a more widespread, albeit subtle, alteration in brain processing. The fluctuating nature of these visual defects mirrors the characteristic waxing and waning course of tics, further suggesting a shared underlying dynamic pathophysiology (Senberg & Roessner, 2021; Enoch et al., 1991).

## Developmental Neurobiology

Provisional Tic Disorder is fundamentally a disorder of neurodevelopment, with a characteristic onset, course, and prognosis that are inextricably linked to the dynamic processes of brain maturation during childhood and adolescence (Rothenberger & Banaschewski, 2006; Senberg & Roessner, 2021). The biological mechanisms underlying PTD cannot be understood without considering the developmental context in which they emerge, fluctuate, and, in most cases, resolve. This period of life is marked by profound changes in neural circuitry, synaptic organization, and neurochemical modulation, creating a window of vulnerability but also of remarkable plasticity (Blows, 2003; Heird & Voigt, 2004).

### Onset and Critical Periods

The onset of tic disorders almost invariably occurs before the age of 18, with most cases beginning between the ages of 3 and 8 years (Vocke & Neuner, 2012; Scahill et al., 2009; Jakubovski & Müller‐Vahl, 2017). This specific age range for onset strongly suggests the involvement of brain systems undergoing significant maturational changes during this time (Rothenberger & Banaschewski, 2006). The early school-age years are a critical period for the refinement of motor control, the development of inhibitory functions, and the consolidation of CSTC pathways (Blows, 2003; Radü, 1987). It is hypothesized that a genetic predisposition interacts with normal developmental processes during this sensitive window, leading to a temporary dysregulation of these circuits and the emergence of tics (Senberg & Roessner, 2021). The brain's development does not proceed uniformly; different systems mature at different rates (Blows, 2003). The emergence of tics during this period may reflect a transient imbalance between the maturation of subcortical motor-generating regions (like the striatum) and the slower-maturing cortical inhibitory regions (like the prefrontal cortex) (Vocke & Neuner, 2012).

The initial presentation often involves simple motor tics, such as eye blinking or facial movements, with phonic tics frequently appearing later (Vocke & Neuner, 2012). This progression from simple to more complex phenomena, and from motor to vocal domains, may mirror the hierarchical and regional maturation of the involved neural circuits. The brain's development during the first few years of life is exceptionally rapid (Heird & Voigt, 2004), and any disruption during this time, whether genetic or environmental, can have lasting consequences (Kirichenko Ei et al., 1985; Hodges & Tizard, 1996).

### Fluctuation, Puberty, and Remission

A hallmark of all tic disorders is their fluctuating course, with symptoms waxing and waning in frequency and severity over various time scales (Senberg & Roessner, 2021). This variability is particularly pronounced during childhood and adolescence. Typically, tic severity increases from the age of onset, reaching a peak around puberty, between the ages of 10 and 12 (Senberg & Roessner, 2021; Rothenberger & Banaschewski, 2006). This pubertal exacerbation strongly implicates the role of hormonal changes in modulating the underlying neural circuitry (Richardson & Tate, 2001). The surge of gonadal steroids during puberty has profound effects on brain organization and neurotransmitter systems, including the dopamine system, which is central to the pathophysiology of tics (Zoppi, 1992; Vocke & Neuner, 2012). This hormonal flux may temporarily destabilize the CSTC circuits, leading to a worsening of symptoms.

Following this peak in early adolescence, a significant majority of individuals experience a marked improvement in their tics (Senberg & Roessner, 2021). For many, particularly those who would have met the criteria for PTD, the tics may disappear entirely by late adolescence or early adulthood (Vocke & Neuner, 2012). This spontaneous remission is a key feature that distinguishes the developmental course of tic disorders from many other neurodevelopmental conditions. It suggests powerful endogenous compensatory mechanisms and ongoing neuroplasticity. As the brain continues to mature through adolescence into the early twenties, particularly with the continued development of the prefrontal cortex and its inhibitory projections, it is likely that top-down control over the dysregulated subcortical circuits is strengthened, leading to better tic suppression and eventual remission (Blows, 2003; Weller, 1995).

Thus, PTD can be viewed as a manifestation of a transient neurodevelopmental imbalance. The initial appearance of tics reflects a vulnerability in the CSTC circuits during a period of rapid organization. The typical course, with a peak around puberty and subsequent decline, mirrors the tumultuous but ultimately organizing processes of adolescent brain maturation. For the majority of children, the developing brain successfully establishes or restores the necessary balance within these circuits, leading to the resolution of symptoms (Senberg & Roessner, 2021). In a smaller subset, this compensatory process is incomplete, leading to the persistence of symptoms and a transition to a chronic tic disorder or Tourette Syndrome (Abi‐Jaoude & Gorman, 2012).

## Treatment Mechanisms

The management of Provisional Tic Disorder, and tic disorders more broadly, involves a range of interventions aimed at reducing tic severity and mitigating their impact on an individual's functioning (Senberg & Roessner, 2021). From a biological standpoint, these treatments are thought to work by modulating the dysfunctional neurobiological systems implicated in tic pathogenesis, primarily the cortico-striato-thalamo-cortical (CSTC) circuits and their associated neurotransmitter systems (Vocke & Neuner, 2012; García-Acero & Espinosa, 2018). The therapeutic approach often begins with psychoeducation, followed by behavioral interventions and, in more severe cases, pharmacotherapy (Vocke & Neuner, 2012).

### Pharmacological Interventions

The most direct evidence for the biological basis of tic treatment comes from pharmacology. The primary medications used for tic suppression are dopamine receptor antagonists, which directly target the hypothesized hyperdopaminergic state within the striatum (Jakubovski & Müller‐Vahl, 2017). By blocking dopamine D2 receptors, these drugs reduce the excitatory drive through the direct pathway of the basal ganglia, thereby increasing the inhibitory output of the CSTC loop and raising the threshold for the execution of unwanted motor programs (Vocke & Neuner, 2012).

Typical antipsychotics like haloperidol, though effective, are no longer considered first-line treatments due to their side effect profiles (Vocke & Neuner, 2012). Atypical antipsychotics such as risperidone and aripiprazol, as well as other agents like tiapride and sulpirid, are now more commonly recommended (Senberg & Roessner, 2021; Vocke & Neuner, 2012). Aripiprazol, for instance, acts as a partial agonist at D2 receptors, which allows it to function as a dopamine system stabilizer—reducing activity in a hyperdopaminergic state while potentially avoiding the complete blockade that can lead to adverse effects (Farias Ferraz et al., 2019). It is important to note that these medications do not cure the underlying disorder but rather provide symptomatic relief by dampening the expression of tics (Senberg & Roessner, 2021). Their use in PTD is generally reserved for cases where tics are causing significant distress or functional impairment, given the transient nature of the disorder and the potential for side effects.

### Behavioral Interventions and Neuroplasticity

Behavioral therapies represent a non-pharmacological approach that is thought to leverage the brain's capacity for neuroplasticity to improve tic control (Senberg & Roessner, 2021). These specialized therapies, while often not readily available, are considered effective (Senberg & Roessner, 2021). The primary mechanism is believed to involve strengthening top-down cognitive control from cortical regions (e.g., prefrontal cortex) over the disinhibited subcortical structures (basal ganglia) that generate tics (Vocke & Neuner, 2012).

Two prominent behavioral approaches are Habit Reversal Training (HRT) and Comprehensive Behavioral Intervention for Tics (CBIT). These therapies involve two core components. The first is awareness training, where the individual learns to recognize the premonitory sensory urges that often precede a tic. The second is competing response training, where the individual learns to perform a voluntary movement that is physically incompatible with the tic when the urge is felt. For example, a person with a head-jerking tic might learn to gently tense their neck muscles to prevent the jerk.

From a neurobiological perspective, this process can be seen as a form of active, targeted neuroplasticity. By repeatedly and consciously engaging competing motor programs, the individual may strengthen the synaptic connections within cortical and subcortical pathways that are responsible for motor inhibition and voluntary control. This may involve enhancing the efficacy of the inhibitory indirect pathway or bolstering the prefrontal cortex's ability to modulate striatal activity. In essence, behavioral therapy trains the brain to re-establish a more effective regulatory balance within the CSTC circuits, empowering the individual to exert more control over their motor output (Senberg & Roessner, 2021).

### Psychoeducation as a Foundational Mechanism

Psychoeducation is considered a fundamental first step in the management of any tic disorder (Vocke & Neuner, 2012). While not a direct biological intervention, its mechanism has significant neurobiological implications. By providing the individual and their family with accurate information about the nature of tics—that they are involuntary, neurobiological in origin, and not a sign of bad behavior—psychoeducation can dramatically reduce anxiety and stress (Pestana, 2015). Since stress and emotional tension are known to exacerbate tics, likely through modulation of catecholaminergic systems like dopamine and norepinephrine, reducing this stress can have a direct tic-suppressing effect (Vocke & Neuner, 2012). This creates a more stable neurochemical environment, which may not only reduce tic frequency but also enhance the individual's capacity to engage with and benefit from other interventions like behavioral therapy.

## Future Directions

While our understanding of the biological basis of tic disorders has advanced significantly, this knowledge is derived almost entirely from studies of chronic and severe forms, such as Tourette Syndrome (TS). The most pressing future direction is the need for dedicated research into the specific neurobiology of Provisional Tic Disorder (PTD) itself. As the most common and typically transient form of tic disorder, PTD offers a unique opportunity to study the initiation, expression, and, most importantly, the resolution of tics. Acknowledging the multifactorial etiology of these disorders, future investigations must integrate genetic, neurobiological, environmental, and psychosocial factors to build a comprehensive model (Senberg & Roessner, 2021).

A critical area for future research is longitudinal neuroimaging. Currently, our models of brain structure and function in tic disorders are based on cross-sectional data, which cannot capture the dynamic changes that characterize these conditions (Vocke & Neuner, 2012). Prospective studies that follow children from the onset of PTD through either remission or progression to a chronic tic disorder are essential. Such studies could use structural and functional MRI to track developmental trajectories in the volume, connectivity, and activity of CSTC circuit components. This would allow researchers to identify potential neural biomarkers that predict whether a child's tics will remit or persist, a question of immense clinical importance. For instance, are there specific patterns of prefrontal cortex maturation or changes in striatal dopamine receptor density that differentiate children who recover from those who do not?

The genetic and molecular basis of tic disorders also requires much deeper investigation. While a strong familial component is recognized (Pestana, 2015; Abi‐Jaoude & Gorman, 2012), the specific genes and molecular pathways remain largely elusive. Current evidence points broadly to genes involved in synaptic connections, but more extensive studies with larger sample sizes are needed to identify specific risk alleles with confidence (García-Acero & Espinosa, 2018). Future genetic research should not only aim to identify susceptibility genes but also explore how these genes interact with each other (epistasis) and with environmental factors (gene-environment interactions) (Unknown, 2019). The potential role of dynamic mutations, such as trinucleotide repeat expansions, should be explored to explain phenomena like anticipation that are sometimes observed in families (Huret, 1997; Chiurazzi & Oostra, 2006).

Furthermore, research into biological subtypes and heterogeneity is crucial. Tic disorders are clinically diverse, often co-occurring with conditions like ADHD and OCD (Senberg & Roessner, 2021). Future studies should aim to link this clinical heterogeneity to underlying biological differences. Are there distinct neurochemical profiles or circuit alterations associated with "pure" tic disorders versus those accompanied by severe OCD or ADHD? Identifying such biological subtypes could pave the way for more personalized and targeted treatment strategies.

Finally, the mechanisms of remission warrant focused study. The fact that a majority of childhood tics resolve spontaneously by early adulthood suggests a powerful capacity for neuroplastic compensation (Senberg & Roessner, 2021; Vocke & Neuner, 2012). Understanding the biological processes that drive this natural recovery is a key frontier. Research could investigate changes in inhibitory neurotransmission, synaptic pruning, or the strengthening of prefrontal control pathways that coincide with tic remission. Elucidating these natural compensatory mechanisms could provide novel targets for therapeutic interventions designed to promote remission in those with more persistent forms of the disorder. In summary, the future of tic disorder research lies in shifting focus from a static view of chronic disease to a dynamic, developmental perspective, with PTD at the center of investigations into the origins and outcomes of these common neurodevelopmental conditions.

## Conclusion

This chapter has synthesized the current understanding of the biological and neurological basis of Provisional Tic Disorder, drawing heavily upon the more extensive research available for chronic tic disorders and Tourette Syndrome. The evidence converges on a model of PTD as a neurodevelopmental disorder rooted in the dysfunction of cortico-striato-thalamo-cortical (CSTC) circuits, which are fundamental to motor control and behavioral regulation (Vocke & Neuner, 2012; García-Acero & Espinosa, 2018). The expression of tics is thought to stem from a state of dopaminergic dysregulation within these circuits, leading to a failure of motor inhibition and the involuntary release of stereotyped movements and vocalizations. This hypothesis is strongly supported by the clinical efficacy of dopamine-antagonizing medications in tic suppression (Jakubovski & Müller‐Vahl, 2017; Senberg & Roessner, 2021).

A substantial body of evidence indicates that a predisposition to tic disorders is heritable, with a complex, multifactorial genetic architecture likely involving numerous genes related to synaptic function and neurodevelopment (Senberg & Roessner, 2021; Pestana, 2015). The characteristic onset of tics in childhood, their peak severity around puberty, and the high rate of spontaneous remission in late adolescence underscore the disorder's tight integration with the dynamic processes of brain maturation (Rothenberger & Banaschewski, 2006; Senberg & Roessner, 2021). The transient nature of PTD, in particular, suggests that for most affected individuals, endogenous neuroplastic and compensatory mechanisms are ultimately successful in restoring balance to the dysregulated neural circuits.

However, it is imperative to reiterate that this model is largely an inference. The near-total absence of biological studies focused specifically on PTD is a critical gap in the scientific literature. We do not yet know if there are unique biological markers that distinguish transient tics from the initial stages of a chronic disorder. Future research must prioritize longitudinal studies that can track the neurobiological evolution of tics from their first appearance, clarifying the mechanisms of both pathogenesis and remission. A deeper understanding of the genetic, cellular, and circuit-level processes at play in PTD will not only refine our diagnostic and therapeutic approaches for this common childhood condition but will also illuminate the fundamental principles of developmental neuroplasticity and the brain's remarkable capacity for self-correction.

## References

1. Abi‐Jaoude, E., & Gorman, D. (2012). Tourette syndrome. Canadian Medical Association Journal. https://doi.org/10.1503/cmaj.120628
2. Ahmed, E. M. A. R. A., & Soliman, G. E. (2018). Risk Factors of Delayed Milestones Among Children Attending Sohag General Hospital. The Egyptian Journal of Hospital Medicine. https://doi.org/10.21608/ejhm.2018.9079
3. Alawi, I. A., Salmi, I. A., Rahbi, F. A., Riyami, M. A., Kalbani, N. A., Ghaithi, B. A., Al‐Mawali, A., & Sayer, J. A. (2019). Molecular Genetic Diagnosis of Omani Patients With Inherited Cystic Kidney Disease. Kidney International Reports. https://doi.org/10.1016/j.ekir.2019.08.012
4. Albuquerque, N. D. F. (2019). Análise de Biomarcadores Inflamatórios fecais em crianças na Primeira Infância submetidas a Estresse Tóxico..
5. Alexandrescu, S. (2021). Congenital and Perinatal Brain Tumors. Cambridge University Press eBooks. https://doi.org/10.1017/9781316671863.049
6. Allen, S., & Goldman, J. L. (2021). Syndromic Sensorineural Hearing Loss. StatPearls.
7. Ap, K., Kumarasinghe, U., & Kt, P. (1997). Does beta thalassaemia major manifest clinically at three months of age?. PubMed.
8. Arduino-Meirelles, A. P., Lacerda, C. B. F. D., & Gil‐da‐Silva‐Lopes, V. L. (2006). Aspectos sobre desenvolvimento de linguagem oral em craniossinostoses sindrômicas. Pró-Fono Revista de Atualização Científica. https://doi.org/10.1590/s0104-56872006000200011
9. Arellano, K. R. I., Monjaráz, E. M. T., Barrios, E. M., Zárate‐Mondragón, F., León, J. F. C., Bustamente, R. C., Michel-Penichet, F., Camid, M. D. L. Á. E. G., Quiroga, U. L., García, C. I. O., Nieto, C. M., Alcaráz, M. R., Jasso, K. A. S., Morán, J., Sierra, A. S., Ortiz, S. V., Rubio, R. G., Gómez, O. J. M., & Ramı́rez-Mayans, J. (2018). Diagnóstico y tratamiento de los trastornos gastrointestinales del eje cerebro-intestino en niños menores de 2 años. Acta Pediátrica de México. https://doi.org/10.18233/apm39no6pp376-3841736
10. Baden, W., Bender, C., Glöckler, M., Ziemer, G., Schäfer, J., Hofbeck, M., & Henschen, M. (2006). Stridor congenitus – im Einzelfall eine differentialdiagnostische Herausforderung. Zeitschrift für Geburtshilfe und Neonatologie. https://doi.org/10.1055/s-2006-943294
11. Baker, R. C. (2001). Pediatric primary care : ill-child care. Lippincott Williams & Wilkins eBooks.
12. Baldaçara, L., Nóbrega, L. P. C., Tengan, S. K., & Maia, A. K. S. N. (2006). Hiperlexia em um caso de autismo e suas hipóteses. Archives of Clinical Psychiatry (São Paulo). https://doi.org/10.1590/s0101-60832006000500007
13. Barazesh, S. (2009). The genetic dimension of height and health: It may be no tall tale: A few inches taller or shorter could signal a risk for some diseases. Science News. https://doi.org/10.1002/scin.2009.5591751018
14. Barg, E., Wikiera, B., Bieniasz, J., & Wasikówa, R. (2001). [Hamartoma as a reason of precocious puberty in a 15-month old boy].. PubMed.
15. Baumgartner, S. E., Rostásy, K., Haberlandt, E., & Baumann, M. (2013). Jeavon syndrome as a differential diagnosis of facial tics. Neuropediatrics. https://doi.org/10.1055/s-0033-1337701
16. Bayet, B., Revençu, N., Castelein, S., Toeuf, C. D., Reychler, H., Sabe, S. A. B., Theys, S., Steenhout, P., Bernard, P., Vikkula, M., & François, G. (2013). La fente labiopalatine et/ou palatine : signe d’appel d’un syndrome rare. Louvain médical.
17. Beblo, S., Schmidt, H., Nickel, P., Kieß, W., & Bartelt, H. (2009). Partielle Trisomie 18 bei einem 7-jährigen Mädchen. Kinder- und Jugendmedizin. https://doi.org/10.1055/s-0038-1628971
18. Beck, F., Maillochon, F., & Richard, J.-B. (2013). Conduites alimentaires perturbées des jeunes. Agora débats/jeunesses.
19. Beck, F., Maillochon, F., & Richard, J.-B. (2013). Conduites alimentaires perturbées des jeunes. Agora débats/jeunesses. https://doi.org/10.3917/agora.063.0128
20. Behnecke, A., Cag, C., Schulz, A., Maier, E. M., & Vlaho, S. (2021). Focal Epilepsy as the First Clinical Manifestation of NCL2 without Dementia. Neuropediatrics. https://doi.org/10.1055/s-0041-1739623
21. Bender, C., Baden, W., Glöckler, M., Ziemer, G., Schäfer, J., Hofbeck, M., & Henschen, M. (2006). Stridor congenitus - im Einzelfall eine differentialdiagnostische Herausforderung. Neuropediatrics. https://doi.org/10.1055/s-2006-946475
22. Biradar, V., & Angadi, S. (2012). Supernumerary teeth: Review of case series. Journal of Interdisciplinary Dentistry. https://doi.org/10.4103/2229-5194.100604
23. Blows, W. T. (2003). Child brain development.. PubMed.
24. Bober, D., & Martin, A. (2006). Understanding Anxiety Disorders in Children and Adolescents: Brief Overview and Update.
25. Bojanowski, V., Hummel, T., & Croy, I. (2012). Isolierte congenitale Anosmie – Klinische und alltägliche Aspekte eines Lebens ohne Geruchssinn. Laryngo-Rhino-Otologie. https://doi.org/10.1055/s-0032-1329949
26. Borensztein, P., & Gilgenkrantz, S. (2006). Développer des traitements pour les maladies rares : ERDITI, un partenariat public-privé pour la recherche thérapeutique. https://doi.org/10.7202/012239ar
27. Brogårdh‐Roth, S., Stjernqvist, K., Matsson, L., & Klingberg, G. (2009). Dental anxiety patterns in adolescents born preterm compared with matched controls. International Journal of Paediatric Dentistry.
28. Buchner, S., Goetz, A., & Hamer, O. (2012). MDCT eines Sinus-coronarius-Defekts als seltene Form eines Vorhofseptumdefekts. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. https://doi.org/10.1055/s-0031-1299067
29. Buczinski, S., Bélanger, A., & Francoz, D. (2009). Tetralogy of Fallot in cattle: a case report and a bibliographic review.. Revue Méd Vét.
30. Byrne, C. C. (2006). Rethinking Environmental Hazards. Journal of Midwifery & Women s Health. https://doi.org/10.1016/j.jmwh.2005.10.016
31. Carvalho, A. A., Faustino, J., Bota, S., & Ferreira, S. (2021). Unusual presentation in cow’s milk protein allergy. BMJ Case Reports. https://doi.org/10.1136/bcr-2021-242080
32. Carvalho, A. C., Matos, J. E., Lira, S., & Reis, A. C. A. D. (2019). Parésia Hipocaliemica em Adolescente: Um Caso Clínico. Acta Médica Portuguesa. https://doi.org/10.20344/amp.10497
33. Chen, Y. J., Rodriguez, D., Richmond, C. A., Hasler, W. L., Levinthal, D. J., Li, B. U., Petrakis, I., Coyne, K. S., Wu, M., Tack, J., & Venkatesan, T. (2024). Symptom Patterns in Adults With Cyclic Vomiting Syndrome: A 6‐Month Prospective Observational Study. Neurogastroenterology & Motility. https://doi.org/10.1111/nmo.14974
34. Chirano, C. B., Resende, G. B. D., Ribeiro, E. A. D. O., & Soares, K. S. (2018). SÍNDROME DE RETT: abordagem odontológica. Revista da AcBO - ISSN 2316-7262.
35. Chiurazzi, P., & Oostra, B. A. (2006). Expanding Mutations/Genetic Anticipation. Encyclopedia of Life Sciences. https://doi.org/10.1038/npg.els.0001463
36. Chávez, C. J., Ortega, P., Miranda, L. E., Leal, J. Y., Escalona, C., & Delgado, C. F. (2015). Aspectos nutricionales de la disfunción tiroidea en niños y adolescentes con síndrome de Down. Archivos Venezolanos de Puericultura y Pediatría.
37. Clamadieu, C., Lorotte-Namouni, S., & Jarreau, P.-H. (2004). Dificultad respiratoria del recién nacido (excepto por malformaciones y enfermedades genéticas o constitucionales). EMC - Pediatría. https://doi.org/10.1016/s1245-1789(04)40754-9
38. Coghill, D., Bonnar, S., Duke, S., Graham, J., & Seth, S. (2009). Abnormalities of child development. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199234998.003.0004
39. Collett, B. R., & Speltz, M. L. (2001). Cleft lip and palate. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511543579.147
40. Conti, G., Bastanza, G., Berrettini, S., Ciciriello, E., Cristi, M. C., Volpe, A. D., Lucia, T. D., Fetoni, A. R., Forli, F., Giuntini, G., Muzzi, E. S., Orzan, E., Picciotti, P. M., Ricci, G., & Carlini, M. D. (2015). Ottenere una definizione di tipo, gravità e morfologia dell’ipoacusia entro 3-6 mesi di vita nel bambino proveniente dallo screening uditivo o entro 1 mese dall’identificazione in caso di ipoacusia Late Onset o Loss to Follow up: raccomandazioni identificate attraverso un’analisi SWOT.
41. Cooper, R. F., Bagwell, C., & Smith, T. (1987). Hearing loss in pediatric meningitis.. PubMed.
42. Corsello, G., & Giuffrè, M. (2018). Congenital Malformations and Syndromes: Early Diagnosis and Prognosis in Neonatal Medicine. Neonatology. https://doi.org/10.1007/978-3-319-29489-6_153
43. Cory‐Slechta, D. A., Sobolewski, M., Varma, G., & Schneider, J. S. (2017). Developmental lead and/or prenatal stress exposures followed by different types of behavioral experience result in the divergence of brain epigenetic profiles in a sex, brain region, and time-dependent manner: Implications for neurotoxicology. Current Opinion in Toxicology. https://doi.org/10.1016/j.cotox.2017.09.004
44. Csorba, J., Ferencz, E. S., Solymossy, M., Vados, M., Páli, E., & Nagy, E. (2007). Diagnoses and detailed behavioural characteristics of self-injurious adolescent outpatients. Mentálhigiéné és Pszichoszomatika. https://doi.org/10.1556/mental.8.2007.2.1
45. Cuadrado, I. P. S. (2015). Validación de los cuestionarios de calidad de vida "Glasgow benefit inventory" y "Nijmegen cochlear implant questionnaire" en pacientes con implante coclear.
46. DALOĞLU, M., & GÜZEL, K. G. U. (2018). Remineralizing Agents&amp;#775;. Turkiye Klinikleri Journal of Dental Sciences. https://doi.org/10.5336/dentalsci.2017-56031
47. Danese, E., & Lippi, G. (2018). Rare diseases: the paradox of an emerging challenge. Annals of Translational Medicine. https://doi.org/10.21037/atm.2018.09.04
48. Dayasiri, K., & Rao, S. (2021). Fifteen-minute consultation: Evaluation of paediatric torticollis. Archives of Disease in Childhood Education & Practice. https://doi.org/10.1136/archdischild-2020-319668
49. Debus, O., Menges-Wenzel, E. M., Sträter, R., Schuierer, G., & Kurlemann, G. (2001). Cockayne-Syndrom mit betonter zerebraler Symptomatik - Verlaufsbeobachtung bei zwei Schwestern -. Klinische Pädiatrie. https://doi.org/10.1055/s-2001-15864
50. Dinçel, N., Kara, O., Özdemir, K., Yılmaz, E., Kutlu, A., Cantürk, G., & Mır, S. (2014). MONOSEMPTOMATİK ENUREZİSLİ ÇOCUKLARDA VE ANNELERİNDE YAŞAM KALİTESİNİN DEĞERLENDİRİLMESİ. Journal of Contemporary Medicine. https://doi.org/10.16899/ctd.41645
51. Drábková, P. (2015). Prevence močové inkontinence ve stáří. Urologie pro praxi.
52. Duan, S. (2021). Down Syndrome. Pediatric Care Online. https://doi.org/10.1542/aap.ppcqr.396156
53. Durmazlar, S. P. K., Atacan, D., Cemil, B. Ç., & Eskioğlu, F. (2009). Is Gardner-Diamond syndrome associated with hormonal influences along with psychosocial problems? A delayed diagnosis. European Journal of Dermatology. https://doi.org/10.1684/ejd.2009.0624
54. Eapen, V., Graham, P. H., & Srinath, S. (2012). Habit disorders. https://doi.org/10.1017/9781009541640.007
55. Edroso-Jarne, P. E., González-Natera, R., Valdivia-Grandez, M. A., & Sánchez-Polo, C. M. (2019). Preeclampsia grave de aparición precoz confirmada con biomarcador.
56. Ei, K., Lf, K., & IuS, S. (1985). [General patterns in the clinical picture, etiology and pathogenesis of neuropsychiatric diseases on a neurotic level in young children].. PubMed.
57. Elpers, C., Fiedler, B., Rödiger, M., Lindén, T., & Kurlemann, G. (2013). Kleine-Levin syndrome in a 10-year-old boy as the rare cause of hypersomnia. Neuropediatrics. https://doi.org/10.1055/s-0033-1337799
58. Enoch, J. M., Khamar, B., & Lakshminarayanan, V. (1991). Step-like field defects in Gilles de la Tourette syndrome. Neuro-Ophthalmology. https://doi.org/10.3109/01658109109036974
59. Epplen, J. T., & Wieczorek, S. (2007). Trinucleotide Repeat Expansions: Mechanisms and Disease Associations. Encyclopedia of Life Sciences. https://doi.org/10.1002/9780470015902.a0005067.pub2
60. Epstein, R. (2001). Voice disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511543579.250
61. Espadero, D. B., & Páez, E. O. (2013). Cólico del lactante. Pediatría Atención Primaria. https://doi.org/10.4321/s1139-76322013000300009
62. Eugster, E. A., & Palmert, M. R. (2006). Precocious Puberty. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem.91.9.9997
63. Faustino, L. H. D. S., & PÉRES, J. V. D. V. (2024). SÍNDROME DE MARFAN: ASPECTOS CLÍNICOS E ACONSELHAMENTO GENÉTICO. https://doi.org/10.51161/geneticon2024/34787
64. Fedorova, L., Savenko, I. V., Vikhnina, S. M., & Boboshko, M. Y. (2021). Childhood hearing screening: achievements, difficulties, and possible ways to improve. Russian Bulletin of Otorhinolaryngology. https://doi.org/10.17116/otorino20218601182
65. Ferraz, K. F., Brito, H. T. S., Barbosa, L. N. D. F., & Sousa, H. F. D. (2019). Aripiprazol na síndrome de tourette em adultos: relato de caso e revisão narrativa. Debates em Psiquiatria. https://doi.org/10.25118/2763-9037.2019.v9.61
66. Ferreira, D. M., Santos, A. P. T., Miranda, K. W., & Salles, F. L. P. (2019). Desenvolvimento rudimentar e intervenção fisioterapêutica na Síndrome de Angelman. Revista Neurociências. https://doi.org/10.34024/rnc.2009.v17.8537
67. Fine, A. L., Wirrell, E., & Nickels, K. (2019). Classifications of Seizures and Epilepsies. Cambridge University Press eBooks. https://doi.org/10.1017/9781108754200.005
68. Freire, V., Lemos, M., Shintome, L. K., Ramos, C. J., & Myaki, S. I. (2009). Natal and neonatal teeth Dentes natal e neonatal.
69. Gallan, L. (2013). La morte improvvisa "sine materia". Sindrome long-Qt congenita o indotta da farmaci. Incidenza del fenomeno nello sportivo..
70. Garbuio, G. C., Mio, J. R., Feltrin, L. C., Silva, M. S., Carneiro, Z. A., & Lourenço, C. M. (2021). Mutação missense de novo patogênica c.2415C G (p.Asp805Glu) no gene ATP1A3 em paciente com hemiplegia alternante da infância com resposta favorável ao cloridrato de biperideno. Medicina (Ribeirão Preto). https://doi.org/10.11606/issn.2176-7262.rmrp.2021.167265
71. García-Acero, M., & Espinosa, E. (2018). Síndrome De Tourette Familiar: Reporte De Caso Y Revisión De La Literatura. Revista Ecuatoriana de Neurologia.
72. Garzi, A., & Messina, M. (2012). Esophageal Atresia. Neonatology. https://doi.org/10.1007/978-88-470-1405-3_89
73. Gesing, J., Specht, A., Pfäffle, R., Kiess, A. P., Körner, A., & Kieß, W. (2017). Geschlechtsdysphorie im Kindes- und Jugendalter. Kinder- und Jugendmedizin. https://doi.org/10.1055/s-0038-1629413
74. Ghirri, P., Balsamo, A., Ciantelli, M., Boldrini, A., & Cicognani, A. (2012). Endocrine Diseases of Newborn. Neonatology. https://doi.org/10.1007/978-88-470-1405-3_121
75. Gomes, I. E. V. E. M., & Rennó, J. (2019). Hipomania no Pós-Parto. Publicações ABP documentos e vídeos ABP Publications documents and videos. https://doi.org/10.25118/issn.2965-1832.2019.654
76. Gomes, S., Lencastre, A., & Lopes, M. J. P. (2012). Alterações ungueais em Pediatria. Nascer e crescer.
77. Gon, K. J., Mi, Y., & Baik, B. J. (2006). 선천성 다수 영구치 결손 환아의 증례보고. THE JOURNAL OF THE KOREAN ACADEMY OF PEDTATRIC DENTISTRY.
78. Guerrero, J. M., Hernández, F. O., & Cabrera, A. B. B. (2012). Luxación traumática de cadera en niños: reporte de un caso de una niña de 4 años. Acta Ortopédica Mexicana.
79. Gupta, N., Sowmya, A. V., Dhamija, S., Samudra, M., Chaudhury, S., & Saldanha, D. (2021). Erotomania. Industrial Psychiatry Journal. https://doi.org/10.4103/0972-6748.328821
80. Hahnemann, M. L., Wittschieber, D., & Becker, P. (2015). „Needles and Pins“: Selbstverletzung durch Ingestion ungewöhnlich zahlreicher scharfer Fremdkörper. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. https://doi.org/10.1055/s-0035-1553271
81. Haque, S., Shafi, B., & Kaleem, M. (2013). Bildgebung bei kindlichem Tortikollis. Neuroradiologie Scan. https://doi.org/10.1055/s-0032-1325850
82. Hasle, H., Abrahamsson, J., Arola, M., Karow, A., O’Marcaigh, A., Reinhardt, D., Webb, D. K. H., Wering, E. V., Zeller, B., Zwaan, C. M., & Vyas, P. (2007). Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML. Leukemia. https://doi.org/10.1038/sj.leu.2405060
83. Heird, W. C., & Voigt, R. G. (2004). Nutritional Inﬂuences on Infant Development. CRC Press eBooks. https://doi.org/10.1201/9780203997338-10
84. Hj, R. (1987). [Significance of results of developmental physiologic studies for therapy of hearing handicapped children].. PubMed.
85. Hodges, J., & Tizard, B. (1996). Family Life. https://doi.org/10.1007/978-1-349-24483-6_34
86. Huret, J. (1997). Phénomène d'anticipation dans les leucémies familiales: vers l'implication de gènes à répétition de trinucléotides?. Hématologie.
87. Hässler, S. (2006). Autoimmune Regulator Deficient Mice, an Animal Model of Autoimmune Polyendocrine Syndrome Type I.
88. Hållberg, F., & Nordin, I. (2019). Talutveckling vid läpp-käk-gomspalt : Samband mellan konsonantproduktion vid 18 månader och 3 år.
89. Ipiales, G., & Soledad., R. (2018). Estimulación temprana en el desarrollo motor de una paciente con distrofia miotónica de steinert.
90. Isser, N., & Schwartz, L. L. (2006). Shaken Baby Syndrome. The Journal of Psychiatry & Law. https://doi.org/10.1177/009318530603400303
91. Jahns, B. E., Silalahi, R., Pieske, B., Stein, W., & Emons, G. (2007). Peripartale Kardiomyopathie – ein Fallbericht. Geburtshilfe und Frauenheilkunde. https://doi.org/10.1055/s-2007-988652
92. Jakubovski, E., & Müller‐Vahl, K. (2017). Gilles de la Tourette-Syndrom: Klinik, Ursachen, Therapie. PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie. https://doi.org/10.1055/s-0043-103269
93. Jamro, E. (2019). Diagnoza i terapia logopedyczna dziecka z zespołem de Grouchy’ego. Wydawnictwo Uniwersytetu Rzeszowskiego eBooks. https://doi.org/10.15584/978-83-7996-731-5_5
94. Jm, D., Bricteux, G., Panagopoulos, A., Makanda, A., & Jm, K. (2002). [Clinical case of the month. Myoclonic-astatic epilepsy in a young child (MAE) or Doose syndrome].. PubMed.
95. Jm, F., Rege, G., Nisolle, M., Pintiaux, A., & Béliard, A. (2012). [Premature ovarian failure, from genetics to clinical].. PubMed.
96. Johnson, M., KA, P., Franco, D., Hagopian, W., Killian, M., Tj, M., Tree, T., Domingo‐Vila, C., Hudson, M., Hammersley, S., Dobbs, R., Ellard, S., Flanagan, S., Hattersley, A. T., & RA, O. (2021). Type 1 diabetes can present before the age of 6 months and is characterized by autoimmunity and rapid loss of beta cells. Yearbook of pediatric endocrinology. https://doi.org/10.1530/ey.18.10.13
97. Júnior, L. D. M. S., Neville, I. S., Menéndez, D. F. D. S., Neto, M. B. C. D. C., Batista, R. L., Figueiredo, E. G., Andrade, A. F. D., & Teixeira, M. J. (2013). Alterações neuroendócrinas em pacientes com traumatismo cranioencefálico. Arquivos Brasileiros de Neurocirurgia Brazilian Neurosurgery. https://doi.org/10.1055/s-0038-1625992
98. Kadu, A., & Jayan, B. (2012). Upper Airway Sleep Disorders in Children: Orthodontist\'s Role. Indian Journal of Sleep Medicine. https://doi.org/10.5958/j.0973-340x.7.2.008
99. Kamphorst, K., Vlieger, A. M., Oosterloo, B. C., Waarlo, S., & Elburg, R. M. V. (2021). Higher risk of allergies at 4–6 years of age after systemic antibiotics in the first week of life. Allergy. https://doi.org/10.1111/all.14829
100. Kargl, S., Kienbauer, M., Pumberger, W., Duba, H. C., Gerstl, S., & Schöfl, R. (2013). Juvenile chronische Pankreatitis. Zeitschrift für Gastroenterologie. https://doi.org/10.1055/s-0033-1347398
101. Kataoka, Y., Fukushima, K., Sugaya, A., & Nishizaki, K. (2012). Approaches for infantile hearing loss : Transmission from Okayama to other prefectures. Okayama Igakkai Zasshi (Journal of Okayama Medical Association). https://doi.org/10.4044/joma.124.155
102. Katić, E. (2019). Psihomotorni razvoj u prve dvije godine života.
103. Kemp, A., Maguire, S., Nuttall, D. E., Collins, P., Dunstan, F., & Farewell, D. (2021). Can TEN4 distinguish bruises from abuse, inherited bleeding disorders or accidents?. Archives of Disease in Childhood. https://doi.org/10.1136/archdischild-2020-320491
104. Kerbeshian, J. (1997). THE CONSTRUCT OF CANALIZATION AND TOURETTE SYNDROME. Perceptual and Motor Skills. https://doi.org/10.2466/pms.84.1.126-126
105. Kerbeshian, J., Burd, L., & Barth, A. E. (1997). The Construct of Canalization and Tourette Syndrome. Perceptual and Motor Skills. https://doi.org/10.2466/pms.1997.84.1.126
106. Khan, R., Kariya, P. B., Mallikarjuna, R., & Singh, A. N. (2015). Fusion of permanent maxillary right central incisor and mesiodens in an 8-year-old child. BMJ Case Reports. https://doi.org/10.1136/bcr-2014-208541
107. Kim, Y.-R., Jung, K.-H., Son, S., & Park, J. (2021). Management of complicated crown fracture by tooth fragment reattachment with fiber post: a case report. Journal of Dental Rehabilitation and Applied Science. https://doi.org/10.14368/jdras.2021.37.4.251
108. Kotrikova, B., & Mühling, J. (2006). Fehlstellung der Orbita aus chirurgischer Sicht. Klinische Monatsblätter für Augenheilkunde. https://doi.org/10.1055/s-2006-926680
109. Kristiansen, M., Maple‐Grødem, J., Alves, G., Arepalli, S., Hernández, D., Iwaki, H., Nalls, M. A., Singleton, A., Tysnes, O., Toft, M., & Pihlstrøm, L. (2018). A paradoxical relationship between family history, onset age, and genetic risk in Parkinson's disease. Movement Disorders. https://doi.org/10.1002/mds.27555
110. Krug, H., Hauptmann, B., Egert, M., & Arnold, G. (2004). Fokale Dystonie der Zehen im Rahmen eines Falxmeningeoms. Aktuelle Neurologie. https://doi.org/10.1055/s-2004-833279
111. Kulalı, F., Köse, M., Çelik, T., Ergon, E. Y., Kalkanlı, O. H., Çolak, R., Yıldız, M., Özdemir, S. A., Yıldırım, T. G., & Çalkavur, Ş. (2019). Inborn errors of metabolism: a three-year experience. Journal of Dr Behcet Uz Children s Hospital. https://doi.org/10.5222/buchd.2019.62533
112. Kumar, R. (2001). Maladie mentale de la mère et troubles sévères de l'attachement mère-nourrisson. Devenir. https://doi.org/10.3917/dev.014.0047
113. Kunz, A., & Iliadis, C. (2012). Cranial Base (CB)/Brain and Immune System of the Fetus and Neonate in Concert in Evolutionary Development. Journal of Neurological Surgery Part B Skull Base. https://doi.org/10.1055/s-0032-1314075
114. Lai, H. J., Zhang, Z., Evans, M. D., Gangnon, R. E., Anderson, É., Gern, J., & Lemanske, R. (2006). Occurrence of Wheezing and Being Overweight in the First Five Years of Life in a Birth Cohort at High Risk for the Development of Asthma/Allergy. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2005.12.338
115. Laita, S. G.-B., Azkona, G., Sánchez, B. R., & Liesa, J. P. (2006). Síndrome de disfunción cognitiva.. Argos: Informativo Veterinario.
116. Lattanzi, L. V. C. M., Pereira, A. C. D. S., Rodrigues, L., Gomes, J. A. D. M., Ribeiro, B. E., Carvalho, L. S., Alves, M. L., & Correa, I. L. A. (2024). Síndrome de Turner, insuficiência ovariana prematura e uma consequente osteoporose: relato de caso. Jornal Brasileiro de Ginecologia. https://doi.org/10.5327/jbg-2965-3711-2024134s1133
117. Lehman, R., & Nance, M. (2013). Family history in juvenile Huntington disease. Neurology. https://doi.org/10.1212/wnl.0b013e31828728ce
118. Lepola, U., Leìnonen, E., & Koponen, H. (2024). Obsessive Compulsive Disorder (OCD). https://doi.org/10.5040/9781839979712.ch-010
119. León, R. C., Ángel, A. G. D., Bustamante, N. A., Reyes, M. D. L. L. R., Sánchez, M. D. C. E., Hernández, E. L., & Ruíz, V. D. C. (2001). Hiperplasia suprarrenal congénita. Acta Pediátrica de México.
120. Lisik, M., Janas–Kozik, M., Krupka-Matuszczyk, I., & Sieroń, A. L. (2012). [Fragile X syndrome--child's and parent's problem].. PubMed.
121. López-Rivera, E., Liu, Y. P., Verbitsky, M., Anderson, B. R., Capone, V., Otto, E. A., Yan, Z., Mitrotti, A., Martino, J., Steers, N. J., Fasel, D., Vukojević, K., Deng, R., Racedo, S. E., Liu, Q., Werth, M., Westland, R., Vivante, A., Makar, G. S., ... Sanna‐Cherchi, S. (2017). Genetic Drivers of Kidney Defects in the DiGeorge Syndrome. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1609009
122. Marchenko, L. A., & Aleksandrova, N. V. (2006). Rol' predstaviteley semeystva transformiruyushchego faktora rosta beta v otsenke ovarial'nogo rezerva u zhenshchin s prezhdevremennoy nedostatochnost'yu yaichnikov. DOAJ (DOAJ: Directory of Open Access Journals).
123. Meglio, A. D., & Mazzarelli, L. L. (2024). Osteopathies from Exogenous Etiology. https://doi.org/10.1007/978-3-031-39347-1_9
124. Mendoza, F. M. (2019). Quiste dentígero en un potrillo de raza polo argentino.
125. Menon, U. (2019). Case Report: Unusual New Onset Seizures.
126. Minami, M. A. Y., Funayama, C. A. R., & Daneluzzi, J. C. (2001). Desenvolvimento motor dissociado: um enfoque em crianças brasileiras.
127. Missaglia, I., Merelli, A. A., Cuccomarino, A. F., Boldrini, A., Cappucciati, M., & Caverzasi, E. (2012). L’episodio psicotico: studio di un caso clinico. Bollettino della Società Medico Chirurgica di Pavia. https://doi.org/10.6092/2039-1404.125.1137
128. MOBARAKİ, S., & Avşar, A. (2021). Pasif Sigara İçiciliğinin Çocuklarda Sistemik ve Ağız-Diş Sağlığına Etkisi. Selcuk Dental Journal. https://doi.org/10.15311/selcukdentj.773109
129. Mondal, R., Sarkar, S., Aggarwal, V., & Sabui, T. (2012). Hyperimmunoglobulin E syndrome with Sjogren's syndrome in a child. South African Journal of Child Health. https://doi.org/10.7196/sajch.384
130. Montano, F. J. D. (2019). Síndrome de banda amniótica un diagnóstico por imágenes. ALERTA Revista Científica del Instituto Nacional de Salud. https://doi.org/10.5377/alerta.v2i2.7921
131. Moroni, C. (2006). Sporadic and variant of Creutzfeldt-Jakob disease in the elderly. Gériatrie et Psychologie Neuropsychiatrie du Viellissement.
132. Moutard, M.-L., Droin-Mollard, M., Gargiulo, M., Missonnier, S., & Héron, D. (2024). Vulnérabilité postnatale liée à une incertitude prénatale : exemple des anomalies du corps calleux. Contraste. https://doi.org/10.3917/cont.060.0139
133. Mudhol, A., Sharma, S., Saujanya, K. P., Ali, F. M., & Aher, V. (2012). “CONGENITAL FACIAL PALSY’’ - A CASE REPORT AND LITERATURE REVIEW”. Journal of Evolution of Medical and Dental Sciences. https://doi.org/10.14260/jemds/180
134. Muñoz, E., Portela, S., Remohı́, J., & Pellicer, A. (2007). Pregnancy in patients with premature ovarian failure. Expert Review of Obstetrics & Gynecology. https://doi.org/10.1586/17474108.2.6.711
135. Narain, P. (2014). Transmission/disequilibrium Tests. DELETED. https://doi.org/10.16943/ptinsa/2014/v80i3/55137
136. Nauñay, V. H. G., Jiménez, G. J. D. L. C., & Bastidas, S. P. M. (2018). Translocación rob(13; 15) (q10; q10): a propósito de un caso. Universitas Médica. https://doi.org/10.11144/javeriana.umed59-2.tran
137. Nelson, D. L., & Zoghbi, H. Y. (2006). Trinucleotide Repeat Expansions: Disorders. Encyclopedia of Life Sciences. https://doi.org/10.1038/npg.els.0005528
138. Niel, C. W. V. (2013). Is Intussusception a Marker for Celiac Disease in Children. Journal watch. https://doi.org/10.1056/pa201301230000002
139. Nield, L. S., & Kamat, D. (2006). Odd Skull Shapes: Heads Up on Diagnosis and Therapy.
140. Näke, A., Pyper, A., Laass, M., & Hübner, A. (2012). Eine seltene Diabetesform: das Wolcott-Rallison-Syndrom (Fallbeschreibung). Diabetologie und Stoffwechsel. https://doi.org/10.1055/s-0032-1314504
141. Oliveira, I. D., Mata, M. F. D., & Alves, M. P. (2019). GRIEF AFTER PERINATAL LOSS – WHEN THE LOSS IS OF SOMEONE WE NEVER MET. https://doi.org/10.26226/morressier.5d1a037b57558b317a140b8a
142. Ortega, J. R. (2006). Síndrome de los estudiantes de bachillerato. Efecto en el aprendizaje. Innovación educativa.
143. Panzica, M., Pape, H., Garapati, R., Zelle, B. A., & Krettek, C. (2004). Long-term outcome of a child with a proximal femur fracture after high-energy trauma. Injury Extra. https://doi.org/10.1016/j.injury.2004.02.006
144. Pasinato, F., Santin, B. B., & Garrastazu, M. D. (2013). ATENDIMENTO ODONTOLOGICO AO PACIENTE COM PARALISIA CEREBRAL LEVE. Ação Odonto.
145. Patwardhan, A., Higgins, G. C., Spencer, C. H., & Rennebohm, R. M. (2012). Juvenile dermatomyositis is a different disease in children up to three years of age at onset than in children above three years at onset. Pediatric Rheumatology. https://doi.org/10.1186/1546-0096-10-s1-a63
146. Pestana, L. (2015). Síndrome de La Tourette. Congresso Internacional de Psicologia da Criança e do Adolescente.
147. Petrunak, J. L. (2017). Everyday Exotropia: Learning from the Littlest. American Orthoptic Journal. https://doi.org/10.3368/aoj.67.1.52
148. Pierce, M. C. (2006). Appendix 1. Injuries, Signs, or Symptoms Where Inflicted Trauma/Physical Abuse is Included in the Differential Diagnosis in Children ≤ 4 Years of Age. Clinical Pediatric Emergency Medicine. https://doi.org/10.1016/j.cpem.2006.08.003
149. Pimentel, G. S. A. (2012). A importância da triagem seriada em prematuros muito baixo peso e a evolução das disfunções tireoidianas detectadas pelo Programa de Triagem Neonatal de Minas Gerais em recém-nascidos retidos em maternidade.
150. Pophali, P. A., Klotz, J. K., Koklanaris, E., Savani, B. N., Chawla, K., Le, R., Wu, C. O., Barrett, J., & Battiwalla, M. (2012). Chronic GVHD and Age Are Not Associated with Bone Mineral Density Loss in the Second Decade Post-Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. https://doi.org/10.1016/j.bbmt.2011.12.202
151. Prati, B. (2006). Les adolescents adoptés sont-ils plus à risque de suicide que leurs pairs non adoptés ?. Adolescence. https://doi.org/10.3917/ado.055.0111
152. Raukas, E., Oitmaa, E., Joost, K., Kruustük, K., Kull, M., Žordania, R., & Teek, R. (2007). Pärilik ehk geneetiline kuulmislangus. Eesti Arst. https://doi.org/10.15157/ea.v0i0.10182
153. Riascos, D. T. V., Bonilla, E. G. C., & Melo, D. (2018). Prevalencia de maloclusión en niños de 7-10 años que asisten a consulta odontológica en la Clínica de Niños I de la Universidad Cooperativa de Colombia sede Pasto primer periodo 2016.
154. Richardson, G. S., & Tate, B. (2001). Endocrine Changes Associated with Puberty and Adolescence. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511499999.006
155. Rivera, V. R. (2012). Mutaciones de la conexina 26 y 30: correlación audiológica.
156. Romanello, S., Spiri, D., Marcuzzi, E., Zanin, A., Boizeau, P., Rivière, S., Vizeneux, A., Moretti, R., Carbajal, R., Mercier, J., Wood, C., Zuccotti, G., Crichiutti, G., Alberti, C., & Titomanlio, L. (2013). 3-Monats-Kolik prophezeit Migräne bei Kindern. Journal Club Schmerzmedizin. https://doi.org/10.1055/s-0033-1358494
157. Rosset, M. O. S. (2009). A sobrecarga na família de crianças com paralisia cerebral. https://doi.org/10.11606/d.22.2009.tde-29102009-135315
158. Rothenberger, A., & Banaschewski, T. (2006). Tic disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511543807.022
159. Ryniewicz, B. (2006). Kanałopatie mięśniowe: miotonie i porażenia okresowe. Polski Przegląd Neurologiczny.
160. Santili, C., Júnior, W. L., Goiano, E. D. O., Lins, R. A. B., Waisberg, G., Braga, S. D. R., & Akkari, M. (2009). Claudicação na criança. Revista Brasileira de Ortopedia. https://doi.org/10.1590/s0102-36162009000400002
161. Scahill, L. D., Bitsko, R. H., Visser, S. N., & Blumberg, S. J. (2009). Prevalence of Diagnosed Tourette Syndrome in Persons Aged 6-17 Years - United States, 2007. PsycEXTRA Dataset. https://doi.org/10.1037/e551952010-002
162. Schneider, S., González, M. M. G., Villalobos, P., Cabacas, A., Mayol, L., & Pérez, E. R. (2006). Ruminació com a causa de distròfia greu en un lactant. Pediatria catalana: butlletí de la Societat Catalana de Pediatria.
163. Scott, M. G., JV, H. M., & Nicholas, T. (2018). Middle Ear Pressure Changes Over Time in Children with Down Syndrome. Journal of Otolaryngology and Rhinology. https://doi.org/10.23937/2572-4193.1510043
164. Senberg, A., & Roessner, V. (2021). Tic-Störungen und Tourette-Syndrom. Kinder- und Jugendmedizin. https://doi.org/10.1055/a-1403-0890
165. Shaarawy, A. O. E. (2019). Pediatric Bipolar Disorder: Diagnosis and Management. Research and Reviews on Healthcare Open Access Journal. https://doi.org/10.32474/rrhoaj.2019.03.000173
166. Simmat-Durand, L., & Vellut, N. (2013). Le Corps sans existence : les enfants victimes de néonaticides. Corps. https://doi.org/10.3917/corp1.011.0243
167. Slomski, A. (2012). Chronic Mental Health Issues in Children Now Loom Larger Than Physical Problems. JAMA. https://doi.org/10.1001/jama.2012.6951
168. Soarès, C., & Toutain, S. (2009). Une cause d'échec scolaire.
169. Spielman, R. S., & Ewens, W. J. (2006). Relatives‐based Test for Linkage Disequilibrium: The Transmission/Disequilibrium Test (TDT). Encyclopedia of Life Sciences. https://doi.org/10.1038/npg.els.0005429
170. Stapleton, F. B. (2019). Scurvy Can Be Mistaken for Rheumatologic Disorders. Journal watch. https://doi.org/10.1056/nejm-jw.na50572
171. Subramanian, D., Impallomeni, M., Mahmood, N., & Joseph, I. (2006). Fraser syndrome in a 96-year-old female. Age and Ageing. https://doi.org/10.1093/ageing/afl109
172. Toldo, C. M., Puga, S. E., & Kairuz, P. V. (2015). Un pequeño ventrículo en una gran aurícula. Insuficiencia Cardiaca.
173. Torres, R. A. B., Euvin, K. E. M., López, G. L. R., & Estrada, E. C. A. (2019). Incidencia de la ruptura prematura de membrana en adolescentes embarazadas. RECIAMUC. https://doi.org/10.26820/reciamuc/3.(1).enero.2019.328-352
174. Tuominen-Eriksson, A.-M., Svensson, Y., & Gunnarsson, R. (2012). Children with Disabilities are Often Misdiagnosed Initially and Children with Neuropsychiatric Disorders are Referred to Adequate Resources 30 Months Later Than Children with Other Disabilities. Journal of Autism and Developmental Disorders. https://doi.org/10.1007/s10803-012-1595-8
175. Unknown (2019). ADHS im Grundschulalter: Jüngere Schüler häufiger betroffen. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/a-0890-9837
176. Unknown (2019). Continued family dysfunction accounts for the association between childhood adversity and adolescent self-harm. https://doi.org/10.13056/acamh.10629
177. Unknown (2019). Epistasis. Definitions. https://doi.org/10.32388/030711
178. Unknown (2019). Genetic anticipation. Definitions. https://doi.org/10.32388/keqite
179. Unknown (2019). ​Autosomal Dominant. Definitions. https://doi.org/10.32388/223097
180. Vieira, M. W., Pires, L. V. L., & Pereira, G. N. (2018). Síndrome de Shprintzen-­Goldberg: relato de dois casos e a importância da genética clínica. Revista da Faculdade de Ciências Médicas de Sorocaba.
181. Vieira, V. B., Nardi, C., Pfuetzenreiter, E. G., & Dedivitis, R. A. (2012). Hemangiopericitoma de língua. Brazilian Journal of Otorhinolaryngology. https://doi.org/10.1590/s1808-86942012000200024
182. Vocke, S., & Neuner, I. (2012). Das Tourette-Syndrom – mehr als „nur“ Tics. PSYCH up2date. https://doi.org/10.1055/s-0032-1305194
183. Watson, W. C. R. (2013). Genetic intraspecific variations. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781316530184.005
184. Weigl, L. B. (2003). Viral Exanthems. Steinkopff eBooks. https://doi.org/10.1007/978-3-7985-1966-4_25
185. Weiß, F., Simon, P., Witt, H., Mayerle, J., Hlouschek, V., Domschke, W., & Lerch, M. M. (2015). SPINK1 Mutationen haben keinen Einfluss auf den Phänotyp oder Verlauf der hereditären Pankreatitis. Zeitschrift für Gastroenterologie. https://doi.org/10.1055/s-0035-1555339
186. Weller, E. B. (1995). Bipolar Disorder in Adolescents. Journal watch. https://doi.org/10.1056/jp199506010000003
187. Wenning, G. K., & Wolf, E. (2007). Autonome Störungen bei Parkinson. Nicht nur im fortgeschrittenen Stadium, sondern zum Teil zu Beginn oder vor Einsetzen der motorischen Symptome können nichtmotorische Störungen auftreten. focus neurogeriatrie. https://doi.org/10.1007/s12151-008-0065-2
188. Wijngaart, W. S. V. D., Huizing, E. H., Niermeijer, M. F., Verschuure, J., Brocaar, M. P., & Blom, W. (1985). Follow-Up Study in a Family with Dominant Progressive Hereditary Sensorineural Hearing Impairment II. Clinical Aspects. International Journal of Audiology. https://doi.org/10.3109/00206098509078352
189. Wilcox, E. R., Riazuddin, S., & Riazuddin, S. (2001). Some Deafness-Causing Mutations Can Be Silenced with the Appropriate Gene Partner. The Scientific World JOURNAL. https://doi.org/10.1100/tsw.2001.40
190. Winczewska‐Wiktor, A., & Steinborn, B. (2012). Dziecięce zespoły okresowe. Polski Przegląd Neurologiczny.
191. Woodward, S. (2009). The 4th National Neuroscience Nursing Conference, Regent's College, London, 12 May 2009: Poster presentations. British Journal of Neuroscience Nursing. https://doi.org/10.12968/bjnn.2009.5.7.43244
192. Xu, C., Wang, T., & Yan, F. (2019). Pituitary Stalk Interruption Syndrome. Journal of Craniofacial Surgery. https://doi.org/10.1097/scs.0000000000005580
193. Xu, W. (2013). [Diagnosis and treatment of pediatric vocal fold paralysis].. PubMed.
194. Zanko, A., Yoon, G., Kramer, J., Guzijan, M., Lin, S., Foster-Barber, A., & Boxer, A. L. (2006). Speech and language delay are early manifestations of juvenile-onset Huntington disease. Neurology. https://doi.org/10.1212/01.wnl.0000238390.86304.4e
195. Zeanah, C. H. (1996). Beyond insecurity: A reconceptualization of attachment disorders of infancy.. Journal of Consulting and Clinical Psychology. https://doi.org/10.1037/0022-006x.64.1.42
196. Zerbib, L. E. (2019). Naissance prématurée et répercussions bucco-dentaires.
197. Zoner, C. S., Amaral, D. T., Natour, J., & Fernandes, A. D. R. C. (2006). Contribuição dos métodos de diagnóstico por imagem na avaliação da espondilólise. Revista Brasileira de Reumatologia. https://doi.org/10.1590/s0482-50042006000400009
198. Zoppi, G. (1992). [Physiology of pubertal maturation].. PubMed.
199. Özer, S., & Tunç, Y. D. D. E. Ş. (2009). ERKEN ÇOCUKLUK ÇAĞI ÇÜRÜKLERİ. Atatürk Üniversitesi Diş Hekimliği Fakültesi Dergisi. https://doi.org/10.17567/dfd.37312
200. Şişman, Y., Ertaş, E. T., & Dündar, M. (2007). Genetik anomalisi olmayan iki oligodonti olgusu. Sağlık Bilimleri Dergisi.